I've found a supporting source for the fluid retention claim, in an excerpt from Holland-Frei Cancer Medicine, 6th edition (from 2003). This separates the effects on the kidney into two categories, depending in part on the drug: mineralocorticoid and glucocorticoid.
Mineralocorticoid effects include
- Loss of potassium and hydrogen
- Increase in extracellular fluid volume
- Increase in sodium retention
Glucocorticoid effects include
- Increase in plasma flow in the kidney
- Increase in sodium retention
Both types of effects can occur in limited frequencies outside the kidney, generally in the gastrointestinal system.
These effects can then lead to a variety of symptoms, including high blood pressure. Mineralocorticoids can cause chronic arterial hypertension through long-term sodium retention. Glucocorticoids can do the same, through several factors (the details of which are unknown):
- Increase in filtration fraction, the ratio of glomerular filtration rate to renal plasma flow[1]
- Increase in glomerular hypertension, high pressure in the glomerular capillaries[2]
- Increase in synthesis of angiotensinogen, a protein involved in regulating blood pressure,[3] and atrial natriuretic peptide[4], a peptide involved in regulating renal blood flow and sodium excretion
- Decrease in the synthesis of prostaglandin, lipids that in the kidney regulate blood flow and vasodilation[5]
- Increase in vasopressor responsiveness (interestingly enough, this can be related to angiotensin II; see Drury et al. (1984))
Vasodilation refers to the size of the capillaries; dilation of the capillaries decreases blood pressure, while the reverse increases blood pressure. This is perhaps the most direct effect of corticosteroids on hypertension and blood pressure.
Note: Here, the superscripts indicate secondary sources that explained the significances of these in more detail (which I included); the textbook merely listed them.
Additional sources cited:
[1]: Costnazo, Linda. Physiology: Cases and Problems
[2]: Juan Macías-Núñez et al. The Aging Kidney in Health and Disease
[3]: AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8) [ Homo sapiens (human) ]
[4]: Claudio Ronco et al. Critical Care Nephorology
[5]: Jasjit Bindra. Prostaglandin Synthesis